168 related articles for article (PubMed ID: 25619885)
1. Symptomatic improvement, increased life-span and sustained cell homing in amyotrophic lateral sclerosis after transplantation of human umbilical cord blood cells genetically modified with adeno-viral vectors expressing a neuro-protective factor and a neural cell adhesion molecule.
Islamov RR; Rizvanov AA; Mukhamedyarov MA; Salafutdinov II; Garanina EE; Fedotova VY; Solovyeva VV; Mukhamedshina YO; Safiullov ZZ; Izmailov AA; Guseva DS; Zefirov AL; Kiyasov AP; Palotas A
Curr Gene Ther; 2015; 15(3):266-76. PubMed ID: 25619885
[TBL] [Abstract][Full Text] [Related]
2. Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice.
Rizvanov AA; Guseva DS; Salafutdinov II; Kudryashova NV; Bashirov FV; Kiyasov AP; Yalvaç ME; Gazizov IM; Kaligin MS; Sahin F; Mukhamedyarov MA; Palotás A; Islamov RR
Exp Biol Med (Maywood); 2011 Jan; 236(1):91-8. PubMed ID: 21163822
[TBL] [Abstract][Full Text] [Related]
3. Tandem Delivery of Multiple Therapeutic Genes Using Umbilical Cord Blood Cells Improves Symptomatic Outcomes in ALS.
Islamov RR; Rizvanov AA; Fedotova VY; Izmailov AA; Safiullov ZZ; Garanina EE; Salafutdinov II; Sokolov ME; Mukhamedyarov MA; Palotás A
Mol Neurobiol; 2017 Aug; 54(6):4756-4763. PubMed ID: 27495938
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
[TBL] [Abstract][Full Text] [Related]
5. Construction of recombinant adenovirus containing picorna-viral 2A-peptide sequence for the co-expression of neuro-protective growth factors in human umbilical cord blood cells.
Garanina EE; Mukhamedshina YO; Salafutdinov II; Kiyasov AP; Lima LM; Reis HJ; Palotás A; Islamov RR; Rizvanov AA
Spinal Cord; 2016 Jun; 54(6):423-30. PubMed ID: 26439843
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of direct and cell-mediated triple-gene therapy in spinal cord injury in rats.
Islamov RR; Izmailov AA; Sokolov ME; Fadeev PO; Bashirov FV; Eremeev AA; Shaymardanova GF; Shmarov MM; Naroditskiy BS; Chelyshev YA; Lavrov IA; Palotás A
Brain Res Bull; 2017 Jun; 132():44-52. PubMed ID: 28529158
[TBL] [Abstract][Full Text] [Related]
7. Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model.
Suzuki M; Svendsen CN
Methods Mol Biol; 2016; 1382():325-36. PubMed ID: 26611598
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of cell-mediated gene therapy for spinal cord injury in mini pigs.
Islamov RR; Sokolov ME; Bashirov FV; Fadeev FO; Shmarov MM; Naroditskiy BS; Povysheva TV; Shaymardanova GF; Yakupov RA; Chelyshev YA; Lavrov IA
Neurosci Lett; 2017 Mar; 644():67-75. PubMed ID: 28213069
[TBL] [Abstract][Full Text] [Related]
9. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy.
Rizvanov AA; Kiyasov AP; Gaziziov IM; Yilmaz TS; Kaligin MS; Andreeva DI; Shafigullina AK; Guseva DS; Kiselev SL; Matin K; Palotás A; Islamov RR
Neurochem Int; 2008 Dec; 53(6-8):389-94. PubMed ID: 18948156
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the efficiency of gene-cell therapy in transgenic mice with amyotrophic lateral sclerosis phenotype.
Mukhamedyarov MA; Rizvanov AA; Safiullov ZZ; Izmailov AA; Sharifullina GA; Solovieva VV; Fedotova VY; Salafutdinov II; Cherenkova EE; Bashirov FV; Kaligin MS; Abdulkhakov SR; Shmarov MM; Logunov DY; Naroditsky BS; Kiyasov AP; Zefirov AL; Islamov RR
Bull Exp Biol Med; 2013 Feb; 154(4):558-61. PubMed ID: 23486603
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Glial Scar, Tissue Sparing, Behavioral Recovery and Axonal Regeneration following Acute Transplantation of Genetically Modified Human Umbilical Cord Blood Cells in a Rat Model of Spinal Cord Contusion.
Mukhamedshina YO; Garanina EE; Masgutova GA; Galieva LR; Sanatova ER; Chelyshev YA; Rizvanov AA
PLoS One; 2016; 11(3):e0151745. PubMed ID: 27003408
[TBL] [Abstract][Full Text] [Related]
12. Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis.
Mòdol-Caballero G; García-Lareu B; Herrando-Grabulosa M; Verdés S; López-Vales R; Pagès G; Chillón M; Navarro X; Bosch A
Neurotherapeutics; 2021 Apr; 18(2):1113-1126. PubMed ID: 33786805
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological, Morphological, and Ultrastructural Features of the Injured Spinal Cord Tissue after Transplantation of Human Umbilical Cord Blood Mononuclear Cells Genetically Modified with the VEGF and GDNF Genes.
Mukhamedshina YO; Gilazieva ZE; Arkhipova SS; Galieva LR; Garanina EE; Shulman AA; Yafarova GG; Chelyshev YA; Shamsutdinova NV; Rizvanov AA
Neural Plast; 2017; 2017():9857918. PubMed ID: 28421147
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adeno-associated virus-mediated global anterograde delivery of glial cell line-derived neurotrophic factor to the spinal cord: comparison of rubrospinal and corticospinal tracts in the rat.
Foust KD; Flotte TR; Reier PJ; Mandel RJ
Hum Gene Ther; 2008 Jan; 19(1):71-82. PubMed ID: 18072858
[TBL] [Abstract][Full Text] [Related]
15. Preventive Triple Gene Therapy Reduces the Negative Consequences of Ischemia-Induced Brain Injury after Modelling Stroke in a Rat.
Markosyan V; Safiullov Z; Izmailov A; Fadeev F; Sokolov M; Kuznetsov M; Trofimov D; Kim E; Kundakchyan G; Gibadullin A; Salafutdinov I; Nurullin L; Bashirov F; Islamov R
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962079
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model.
Krakora D; Mulcrone P; Meyer M; Lewis C; Bernau K; Gowing G; Zimprich C; Aebischer P; Svendsen CN; Suzuki M
Mol Ther; 2013 Aug; 21(8):1602-10. PubMed ID: 23712039
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice.
Hwang DH; Lee HJ; Park IH; Seok JI; Kim BG; Joo IS; Kim SU
Gene Ther; 2009 Oct; 16(10):1234-44. PubMed ID: 19626053
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis.
Mohajeri MH; Figlewicz DA; Bohn MC
Hum Gene Ther; 1999 Jul; 10(11):1853-66. PubMed ID: 10446925
[TBL] [Abstract][Full Text] [Related]
19. Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1
Thomsen GM; Alkaslasi M; Vit JP; Lawless G; Godoy M; Gowing G; Shelest O; Svendsen CN
Gene Ther; 2017 Apr; 24(4):245-252. PubMed ID: 28276446
[TBL] [Abstract][Full Text] [Related]
20. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.
Kaspar BK; Lladó J; Sherkat N; Rothstein JD; Gage FH
Science; 2003 Aug; 301(5634):839-42. PubMed ID: 12907804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
